This may be a turning point in treating neurodegenerative diseases

Monday, December 18, 2017

The Guardian, by Hannah Devlin

Success in trials for Huntington’s and Spinal Muscular Atrophy raises hopes that diseases such as Alzheimer’s and ALS could be tackled using a new class of drugs. Read more.